TABLE 1.
Summary of Systematic Reviews Evaluating Immunogenicity After the Primary Series and Booster Dose for 2- and 3-dose Primary Series
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.